Clinical Trial Update: Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating phenylbutyrate in patients with refractory solid tumors or lymphoma, conducted by the National Cancer Institute; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED